TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Klaria Pharma Holding AB (publ)
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
0
|
527
|
0 |
| Financial expenses |
341
|
781
|
336 |
| Earnings before taxes |
-1,662
|
-5,720
|
-5,236 |
| EBITDA |
-1,322
|
-4,940
|
-4,900 |
| Total assets |
6,574
|
10,808
|
11,568 |
| Current assets |
6,572
|
3,663
|
2,719 |
| Current liabilities |
2,867
|
3,940
|
4,681 |
| Equity capital |
3,707
|
6,837
|
6,787 |
| - share capital |
160
|
117
|
84 |
| Employees (average) |
7
|
8
|
6 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
56.4%
|
63.3%
|
58.7% |
| Turnover per employee |
0
|
66
|
0 |
| Profit as a percentage of turnover | -1085.4% | ||
| Return on assets (ROA) |
-20.1%
|
-45.7%
|
-42.4% |
| Current ratio |
229.2%
|
93.0%
|
58.1% |
| Return on equity (ROE) |
-44.8%
|
-83.7%
|
-77.1% |
| Change turnover |
-529
|
527
|
0 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
2
|
0 |
| Chg. No. of employees % |
-13%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.